Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation

Noriyuki Shibata, Asao Hirano, E. Tessa Hedley-Whyte, Mauro C. Dal Canto, Ryoji Nagai, Koji Uchida, Seikoh Horiuchi, Motoko Kawaguchi, Tomoko Yamamoto, Makio Kobayashi

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Recent studies have documented carbonyl stress involvement in the pathogenesis of sporadic amyotrophic lateral sclerosis (ALS). The aim of the present study was to assess a role for carbonyl stress in motor neuron degeneration associated with superoxide dismutase-1 (SOD1) mutant familial ALS and its transgenic mouse model, using an immunohistochemical investigation of advanced glycation end products (AGEs) and advanced lipoxidation end products (ALEs). In the spinal cords from six familial ALS patients with SOD1 A4V mutation and six transgenic mice expressing G93A mutant human SOD1, immunoreactivities for Nε-(carboxyethyl)lysine, argpyrimidine, pyrraline and Nε-(carboxymethyl)lysine as AGEs were distinct in almost all of the reactive astrocytes and obscure in the residual neurons, whereas no immunoreactivity for pentosidine as an AGE, or 4-hydroxy-2-nonenalhistidine, malondialdehyde-lysine or acrolein-lysine as ALEs was detectable. Spinal cords from age-matched control humans and mice exhibited no significant immunoreactivities for the examined products. Our results indicate that protein glycation, but not lipid peroxidation, is enhanced in ALS patients with an SOD1 mutation and mutant SOD1 transgenic mice, in which certain AGEs are selectively formed in the spinal cord astrocytes.

Original languageEnglish (US)
Pages (from-to)171-178
Number of pages8
JournalActa Neuropathologica
Volume104
Issue number2
DOIs
StatePublished - 2002

Fingerprint

Advanced Glycosylation End Products
Astrocytes
Spinal Cord
Mutation
Transgenic Mice
Lysine
Acrolein
Nerve Degeneration
Amyotrophic Lateral Sclerosis
Motor Neurons
Malondialdehyde
Lipid Peroxidation
Superoxide Dismutase-1
Neurons
Amyotrophic lateral sclerosis 1
Proteins

Keywords

  • Advanced glycation end products
  • Amyotrophic lateral scalerosis
  • Astrocyte
  • Superoxide dismutase
  • Transgenic mice

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation. / Shibata, Noriyuki; Hirano, Asao; Hedley-Whyte, E. Tessa; Dal Canto, Mauro C.; Nagai, Ryoji; Uchida, Koji; Horiuchi, Seikoh; Kawaguchi, Motoko; Yamamoto, Tomoko; Kobayashi, Makio.

In: Acta Neuropathologica, Vol. 104, No. 2, 2002, p. 171-178.

Research output: Contribution to journalArticle

Shibata, N, Hirano, A, Hedley-Whyte, ET, Dal Canto, MC, Nagai, R, Uchida, K, Horiuchi, S, Kawaguchi, M, Yamamoto, T & Kobayashi, M 2002, 'Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation', Acta Neuropathologica, vol. 104, no. 2, pp. 171-178. https://doi.org/10.1007/s00401-002-0537-5
Shibata, Noriyuki ; Hirano, Asao ; Hedley-Whyte, E. Tessa ; Dal Canto, Mauro C. ; Nagai, Ryoji ; Uchida, Koji ; Horiuchi, Seikoh ; Kawaguchi, Motoko ; Yamamoto, Tomoko ; Kobayashi, Makio. / Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation. In: Acta Neuropathologica. 2002 ; Vol. 104, No. 2. pp. 171-178.
@article{9fccc5744a5f48eaa781d20a9392bfca,
title = "Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation",
abstract = "Recent studies have documented carbonyl stress involvement in the pathogenesis of sporadic amyotrophic lateral sclerosis (ALS). The aim of the present study was to assess a role for carbonyl stress in motor neuron degeneration associated with superoxide dismutase-1 (SOD1) mutant familial ALS and its transgenic mouse model, using an immunohistochemical investigation of advanced glycation end products (AGEs) and advanced lipoxidation end products (ALEs). In the spinal cords from six familial ALS patients with SOD1 A4V mutation and six transgenic mice expressing G93A mutant human SOD1, immunoreactivities for Nε-(carboxyethyl)lysine, argpyrimidine, pyrraline and Nε-(carboxymethyl)lysine as AGEs were distinct in almost all of the reactive astrocytes and obscure in the residual neurons, whereas no immunoreactivity for pentosidine as an AGE, or 4-hydroxy-2-nonenalhistidine, malondialdehyde-lysine or acrolein-lysine as ALEs was detectable. Spinal cords from age-matched control humans and mice exhibited no significant immunoreactivities for the examined products. Our results indicate that protein glycation, but not lipid peroxidation, is enhanced in ALS patients with an SOD1 mutation and mutant SOD1 transgenic mice, in which certain AGEs are selectively formed in the spinal cord astrocytes.",
keywords = "Advanced glycation end products, Amyotrophic lateral scalerosis, Astrocyte, Superoxide dismutase, Transgenic mice",
author = "Noriyuki Shibata and Asao Hirano and Hedley-Whyte, {E. Tessa} and {Dal Canto}, {Mauro C.} and Ryoji Nagai and Koji Uchida and Seikoh Horiuchi and Motoko Kawaguchi and Tomoko Yamamoto and Makio Kobayashi",
year = "2002",
doi = "10.1007/s00401-002-0537-5",
language = "English (US)",
volume = "104",
pages = "171--178",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation

AU - Shibata, Noriyuki

AU - Hirano, Asao

AU - Hedley-Whyte, E. Tessa

AU - Dal Canto, Mauro C.

AU - Nagai, Ryoji

AU - Uchida, Koji

AU - Horiuchi, Seikoh

AU - Kawaguchi, Motoko

AU - Yamamoto, Tomoko

AU - Kobayashi, Makio

PY - 2002

Y1 - 2002

N2 - Recent studies have documented carbonyl stress involvement in the pathogenesis of sporadic amyotrophic lateral sclerosis (ALS). The aim of the present study was to assess a role for carbonyl stress in motor neuron degeneration associated with superoxide dismutase-1 (SOD1) mutant familial ALS and its transgenic mouse model, using an immunohistochemical investigation of advanced glycation end products (AGEs) and advanced lipoxidation end products (ALEs). In the spinal cords from six familial ALS patients with SOD1 A4V mutation and six transgenic mice expressing G93A mutant human SOD1, immunoreactivities for Nε-(carboxyethyl)lysine, argpyrimidine, pyrraline and Nε-(carboxymethyl)lysine as AGEs were distinct in almost all of the reactive astrocytes and obscure in the residual neurons, whereas no immunoreactivity for pentosidine as an AGE, or 4-hydroxy-2-nonenalhistidine, malondialdehyde-lysine or acrolein-lysine as ALEs was detectable. Spinal cords from age-matched control humans and mice exhibited no significant immunoreactivities for the examined products. Our results indicate that protein glycation, but not lipid peroxidation, is enhanced in ALS patients with an SOD1 mutation and mutant SOD1 transgenic mice, in which certain AGEs are selectively formed in the spinal cord astrocytes.

AB - Recent studies have documented carbonyl stress involvement in the pathogenesis of sporadic amyotrophic lateral sclerosis (ALS). The aim of the present study was to assess a role for carbonyl stress in motor neuron degeneration associated with superoxide dismutase-1 (SOD1) mutant familial ALS and its transgenic mouse model, using an immunohistochemical investigation of advanced glycation end products (AGEs) and advanced lipoxidation end products (ALEs). In the spinal cords from six familial ALS patients with SOD1 A4V mutation and six transgenic mice expressing G93A mutant human SOD1, immunoreactivities for Nε-(carboxyethyl)lysine, argpyrimidine, pyrraline and Nε-(carboxymethyl)lysine as AGEs were distinct in almost all of the reactive astrocytes and obscure in the residual neurons, whereas no immunoreactivity for pentosidine as an AGE, or 4-hydroxy-2-nonenalhistidine, malondialdehyde-lysine or acrolein-lysine as ALEs was detectable. Spinal cords from age-matched control humans and mice exhibited no significant immunoreactivities for the examined products. Our results indicate that protein glycation, but not lipid peroxidation, is enhanced in ALS patients with an SOD1 mutation and mutant SOD1 transgenic mice, in which certain AGEs are selectively formed in the spinal cord astrocytes.

KW - Advanced glycation end products

KW - Amyotrophic lateral scalerosis

KW - Astrocyte

KW - Superoxide dismutase

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=0036938699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036938699&partnerID=8YFLogxK

U2 - 10.1007/s00401-002-0537-5

DO - 10.1007/s00401-002-0537-5

M3 - Article

VL - 104

SP - 171

EP - 178

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 2

ER -